Screener
Perspective Therapeutics CATX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable and accrued expenses | $29,418 | $20,511 |
| Lease liability | 1,097 | 623 |
| Accrued personnel expenses | 5,972 | 7,489 |
| Note payable | 57 | 56 |
| Total current liabilities | 36,544 | 28,679 |
| Noncurrent liabilities: | ||
| Lease liability, net of current portion | 1,269 | 1,005 |
ITEM 1 - FINANCIAL STATEMENTS
FAQ
- What is Perspective Therapeutics's accrued expenses?
- Perspective Therapeutics (CATX) reported accrued expenses of $5.97M in Q2 2026.
- How has Perspective Therapeutics's accrued expenses changed year-over-year?
- Perspective Therapeutics's accrued expenses increased by 18.6% year-over-year, from $5.04M to $5.97M.
- What is the long-term trend for Perspective Therapeutics's accrued expenses?
- Over 5 years (2020 to 2025), Perspective Therapeutics's accrued expenses has grown at a 136.6% compound annual growth rate (CAGR), from $101K to $7.49M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Perspective Therapeutics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude